Zuclopenthixol Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 10 mg, 25 mg, 40 mg
Reference Brands: Clopixol®(EU)
Category: Antipsychotropic Drugs
Zuclopenthixol tablets is available in Oral Tablets and strengths such as 10 mg, 25 mg, 40 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Zuclopenthixol tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Zuclopenthixol tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Zuclopenthixol tablets, used for managing schizophrenia and chronic psychoses, are not FDA-approved in the United States but are authorized in the European Union under the brand Clopixol. EU regulations require GMP compliance, pharmacovigilance systems, and bioequivalence data for registration. U.S. market entry would require a 505(b)(2) or ANDA submission with complete CMC, clinical, and labeling documentation. Regulatory focus includes psychiatric safety profiling and consistent release characteristics. For dossier-ready Zuclopenthixol tablets and to explore other available forms such as IM injections and depot formulations, visit Pharmatradz.com — your trusted platform for global pharmaceutical sourcing.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Amoxapine
Strength:
25 mg, 50 mg, 100 mg, 150 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Amisulpride
Strength:
5 mg/2 mL, 50 mg, 100 mg, 200 mg
Form: Tablets / injectable solutions
Reference Brands: Barhemsys (USA), Solian (EU)
View Details
Risperidone Long-Acting Injection
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)
Strength:
200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
